Suspension-Based Intracellular Immunofluorescence Staining Coupled With Genome-Wide CRISPR-Cas9 Screening to Identify Regulators of O-GlcNAcylation
6 affiliations
- 1Institute of Cytology and Genetics, School of Basic Medical Sciences, Hengyang Medical School, University of South China, Hengyang, Hunan, China
- 2Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, China
- 3Hunan Key Laboratory of Molecular Precision Medicine, Department of Oncology, Xiangya Hospital, Central South University, Changsha, China
- 4Furong Laboratory, Changsha, China
- 5National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China
- 6The Biobank of Xiangya Hospital, Central South University, Changsha, China
Abstract
Protein O-GlcNAcylation is a dynamic and reversible post-translational modification that regulates diverse cellular processes, including transcription, signal transduction, metabolism, and cell fate determination. Systematic identification of genes that modulate global O-GlcNAc levels remains technically challenging at the genome scale. Here, we describe a pooled CRISPR-Cas9 screening protocol that combines the human genome-scale CRISPR knockout (GeCKO) v2 knockout library with intracellular immunofluorescence staining using the anti-O-GlcNAc antibody RL2 and fluorescence-activated cell sorting (FACS). In this workflow, HEK293T cells are transduced with the GeCKO v2 lentiviral library at a low multiplicity of infection to ensure predominantly single-sgRNA integration. Following puromycin selection, cells are fixed, permeabilized, and stained in suspension with RL2. The top 5% of cells with the highest intracellular RL2 fluorescence are collected as the RL2-high population, while a corresponding unsorted/input sample is retained as the reference for downstream sgRNA enrichment analysis. Genomic DNA is recovered from the RL2-high and unsorted/input samples, and integrated sgRNA cassettes are amplified through a two-step PCR and library-preparation workflow for Illumina sequencing. This protocol enables the identification of candidate genes whose knockout is associated with increased intracellular RL2 fluorescence.
Key features
• A genome-scale pooled CRISPR-Cas9 screening workflow using the human GeCKO v2 library in HEK293T cells.
• A suspension-based intracellular RL2 immunofluorescence staining protocol optimized to minimize cell loss during fixation, permeabilization, and washing, thereby preserving sgRNA library representation for downstream sorting.
• Isolation of the top 5% RL2-high population, with a corresponding unsorted/input sample retained as the reference for downstream sgRNA enrichment analysis.
• -Fixed-cell genomic DNA recovery and sgRNA sequencing coupled with model-based analysis of genome-wide CRISPR/Cas9 knockout (MAGeCK) enable robust hit identification.
Related
- A Cell-based Screening Method Using an Intracellular Antibody for Discovering Small Molecules Targeting Hard-to-drug Proteins
- Immunofluorescence: quantitative considerations.
- O-GlcNAcylation in macrophage functions
- HPV E6/E7, O-GlcNAcylation and mitochondrial remodeling in cervical cancer: mechanistic links and translational opportunities
- Protocol for Mouse Embryonic Aorta-Gonad-Mesonephros (AGM) Region Frozen Sectioning and Immunofluorescence.
BibTeX
@article{liu2026suspensionbased,
title = {{Suspension-Based Intracellular Immunofluorescence Staining Coupled With Genome-Wide CRISPR-Cas9 Screening to Identify Regulators of O-GlcNAcylation}},
author = {Peiyu Liu and Qin Lei and Na Zhang and Haibin Yu and Fang Chen and Kai Yuan},
journal = {Bio-protocol},
year = {2026},
month = nov,
doi = {10.21769/bioprotoc.5858},
url = {https://doi.org/10.21769/bioprotoc.5858},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Suspension-Based Intracellular Immunofluorescence Staining Coupled With Genome-Wide CRISPR-Cas9 Screening to Identify Regulators of O-GlcNAcylation
AU - Peiyu Liu
AU - Qin Lei
AU - Na Zhang
AU - Haibin Yu
AU - Fang Chen
AU - Kai Yuan
PY - 2026
DA - 2026/11/05
JO - Bio-protocol
DO - 10.21769/bioprotoc.5858
UR - https://doi.org/10.21769/bioprotoc.5858
AB - Protein O-GlcNAcylation is a dynamic and reversible post-translational modification that regulates diverse cellular processes, including transcription, signal transduction, metabolism, and cell fate determination. Systematic identification of genes that modulate global O-GlcNAc levels remains technically challenging at the genome scale. Here, we describe a pooled CRISPR-Cas9 screening protocol that combines the human genome-scale CRISPR knockout (GeCKO) v2 knockout library with intracellular immunofluorescence staining using the anti-O-GlcNAc antibody RL2 and fluorescence-activated cell sorting (FACS). In this workflow, HEK293T cells are transduced with the GeCKO v2 lentiviral library at a low multiplicity of infection to ensure predominantly single-sgRNA integration. Following puromycin selection, cells are fixed, permeabilized, and stained in suspension with RL2. The top 5% of cells with the highest intracellular RL2 fluorescence are collected as the RL2-high population, while a corresponding unsorted/input sample is retained as the reference for downstream sgRNA enrichment analysis. Genomic DNA is recovered from the RL2-high and unsorted/input samples, and integrated sgRNA cassettes are amplified through a two-step PCR and library-preparation workflow for Illumina sequencing. This protocol enables the identification of candidate genes whose knockout is associated with increased intracellular RL2 fluorescence. Key features • A genome-scale pooled CRISPR-Cas9 screening workflow using the human GeCKO v2 library in HEK293T cells. • A suspension-based intracellular RL2 immunofluorescence staining protocol optimized to minimize cell loss during fixation, permeabilization, and washing, thereby preserving sgRNA library representation for downstream sorting. • Isolation of the top 5% RL2-high population, with a corresponding unsorted/input sample retained as the reference for downstream sgRNA enrichment analysis. • -Fixed-cell genomic DNA recovery and sgRNA sequencing coupled with model-based analysis of genome-wide CRISPR/Cas9 knockout (MAGeCK) enable robust hit identification.
SN - 2331-8325
ER -